tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market

Eton Pharmaceuticals (ETON) Income Statement

Compare
455 Followers

Eton Pharmaceuticals Income Statement

Last quarter (Q3 2024), Eton Pharmaceuticals's total revenue was $10.32M, an increase of 46.90% from the same quarter last year. In Q3, Eton Pharmaceuticals's net income was $627.00K. See Eton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 31.64M$ 21.25M$ 21.83M$ 39.00K$ 959.00K
Gross Profit
$ 21.06M$ 14.32M$ 19.21M$ -247.00K$ 506.00K
Operating Expenses
$ 22.25M$ 22.58M$ 20.70M$ 26.86M$ 19.11M
Depreciation and Amortization
$ 901.00K$ 1.76M$ 447.00K$ 651.00K$ 447.00K
EBITDA
$ -291.00K$ -6.49M$ -1.12M$ -26.46M$ -18.15M
Operating Income
$ -1.19M$ -8.26M$ -1.50M$ -27.11M$ -18.60M
Other Income/Expenses
$ 503.00K$ -761.00K$ -460.00K$ -859.00K$ 281.00K
Pretax Income
$ -689.00K$ -9.02M$ -1.96M$ -27.97M$ -18.32M
Net Income
$ -936.00K$ -9.78M$ -2.96M$ -28.83M$ -18.04M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.04$ -0.39$ -0.12$ -1.37$ -1.02
Diluted EPS
$ -0.04$ -0.39$ -0.12$ -1.37$ -1.02
Weighted Average Shares Outstanding
25.64M 25.15M 25.21M 21.01M 17.76M
Weighted Average Shares Outstanding (Diluted)
25.65M 25.15M 25.21M 21.01M 17.76M
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis